Investors
Portfolio Metrics
35+
Approved products
11
Development-stage therapies
15
Blockbuster $1Bn+ therapies in portfolio
~12 Years
Portfolio weighted average royalty duration
Financial Metrics
$2.8Bn
Adjusted Cash Receipts (2022)
$2.2Bn
Adjusted Cash Flow (2022)
$1.8Bn
Average annual capital deployment since 2012